The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nuclear Medicine & Radiopharmaceuticals Market Research Report 2024
Synopsis
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
The global Nuclear Medicine & Radiopharmaceuticals market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine & Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine & Radiopharmaceuticals.
Report Scope
The Nuclear Medicine & Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine & Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine & Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Segment by Type
Diagnostic
Therapeutic
Segment by Application
Oncology
Thyroid
Cardiology
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nuclear Medicine & Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nuclear Medicine & Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.
The global Nuclear Medicine & Radiopharmaceuticals market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine & Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine & Radiopharmaceuticals.
Report Scope
The Nuclear Medicine & Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine & Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine & Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Segment by Type
Diagnostic
Therapeutic
Segment by Application
Oncology
Thyroid
Cardiology
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nuclear Medicine & Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nuclear Medicine & Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nuclear Medicine & Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Nuclear Medicine & Radiopharmaceuticals
1.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Type (2024-2030)
1.2.2 Diagnostic
1.2.3 Therapeutic
1.3 Nuclear Medicine & Radiopharmaceuticals Segment by Application
1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Value by Application: (2024-2030)
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Global Nuclear Medicine & Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue 2019-2030
1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Sales 2019-2030
1.4.3 Global Nuclear Medicine & Radiopharmaceuticals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nuclear Medicine & Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Nuclear Medicine & Radiopharmaceuticals Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Product Type & Application
2.7 Nuclear Medicine & Radiopharmaceuticals Market Competitive Situation and Trends
2.7.1 Nuclear Medicine & Radiopharmaceuticals Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nuclear Medicine & Radiopharmaceuticals Players Market Share by Revenue
2.7.3 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nuclear Medicine & Radiopharmaceuticals Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region: 2025-2030
3.3 Global Nuclear Medicine & Radiopharmaceuticals Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2025-2030
3.4 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2030)
3.6.3 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 China Isotope & Radiation
6.1.1 China Isotope & Radiation Corporation Information
6.1.2 China Isotope & Radiation Description and Business Overview
6.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.1.5 China Isotope & Radiation Recent Developments/Updates
6.2 Dongcheng
6.2.1 Dongcheng Corporation Information
6.2.2 Dongcheng Description and Business Overview
6.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.2.5 Dongcheng Recent Developments/Updates
6.3 Jaco
6.3.1 Jaco Corporation Information
6.3.2 Jaco Description and Business Overview
6.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.3.5 Jaco Recent Developments/Updates
6.4 Ciaeriar
6.4.1 Ciaeriar Corporation Information
6.4.2 Ciaeriar Description and Business Overview
6.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.4.5 Ciaeriar Recent Developments/Updates
6.5 Advanced Molecular-imaging Solution
6.5.1 Advanced Molecular-imaging Solution Corporation Information
6.5.2 Advanced Molecular-imaging Solution Description and Business Overview
6.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.5.5 Advanced Molecular-imaging Solution Recent Developments/Updates
6.6 Shanghai Atom Kexing
6.6.1 Shanghai Atom Kexing Corporation Information
6.6.2 Shanghai Atom Kexing Description and Business Overview
6.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Portfolio
6.6.5 Shanghai Atom Kexing Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Medicine & Radiopharmaceuticals Industry Chain Analysis
7.2 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Medicine & Radiopharmaceuticals Production Mode & Process
7.4 Nuclear Medicine & Radiopharmaceuticals Sales and Marketing
7.4.1 Nuclear Medicine & Radiopharmaceuticals Sales Channels
7.4.2 Nuclear Medicine & Radiopharmaceuticals Distributors
7.5 Nuclear Medicine & Radiopharmaceuticals Customers
8 Nuclear Medicine & Radiopharmaceuticals Market Dynamics
8.1 Nuclear Medicine & Radiopharmaceuticals Industry Trends
8.2 Nuclear Medicine & Radiopharmaceuticals Market Drivers
8.3 Nuclear Medicine & Radiopharmaceuticals Market Challenges
8.4 Nuclear Medicine & Radiopharmaceuticals Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
